Osteoporosis is an enormous and growing public health problem. Once considered an
inevitable consequence of ageing, it is now eminently preventable and treatable. Ironically …

Osteoporosis is the most prevalent metabolic bone disease that affects half the women in the
sixth and seventh decade of life. Osteoporosis is characterized by uncoupled bone …

Vitamin D (VD) is essential for bone homeostasis, but it is also involved in pleiotropic effects
on various organs and tissues. In adults, VD deficiency can cause or exacerbate …

Introduction: Currently, 424 million people aged between 20 and 79 years worldwide are
diabetic. More than 25% of adults aged over 65 years in North America have Type 2 …

The study was conducted to illustrate the effect of Romosozumab in postmenopausal
osteoporosis patients. Romosozumab decreased the incidence of vertebral, nonvertebral …

Although numerous organ‐on‐a‐chips have been developed, bone‐on‐a‐chip platforms
have rarely been reported because of the high complexity of the bone microenvironment …

Osteoporosis (OP) is a major global health concern, with aging being one of the most
important risk factors. Osteoarthritis (OA) is also an age-related disorder. Patients with OP …

Osteoporosis is a systemic skeletal disease associated with reduced bone strong point that
results in raised fracture risk, with decreased bone strength, leading to reduced bone …

Patients with osteoporosis and chronic kidney disease (CKD) are at increased risk of
fracture and associated negative outcomes, including increased mortality. The present post …

Objective In this study, we aimed to establish the causal effects of lowering sclerostin, target
of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. Methods …